|
|
||||||||
Radiology, Vol 120, 167-171, Copyright © 1976 by Radiological Society of North America
ARTICLES |
JR Harris and MB Levene
Of 55 patients with pituitary adenomas or craniopharyngiomas treated with irradiation, a retrospective study revealed that 5 sustained a visual loss compatible with radiation damage to the optic nerve. No patient who received less than 250 rads/day fractions showed such visual loss. Within the range of total dosages used in this series, total dose was not an important determinant of this complication. The time to occurrence of visual disturbance ranged from 5 to 34 months following therapy.
This article has been cited by other articles:
![]() |
N. Karavitaki, S. Cudlip, C. B. T. Adams, and J. A. H. Wass Craniopharyngiomas Endocr. Rev., June 1, 2006; 27(4): 371 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Yang and R. H. Matthews Prophylactic Cranial Irradiation in Small-Cell Lung Cancer Oncologist, August 1, 2000; 5(4): 293 - 298. [Abstract] [Full Text] |
||||
![]() |
C. Chiquet, D. Milea, P. Romestaing, J.-P. Gérard, P. Martin, and F. Koenig Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration Br. J. Ophthalmol., August 1, 1999; 83(8): 923 - 928. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |